市场调查报告书
商品编码
1492637
DVT 预防帮浦市场:按类型、最终用户划分 - 2024-2030 年全球预测DVT Preventive Pump Market by Type (Intermittent Pneumatic Compression Devices, Sequential Compression Devices), End User (Hospitals & Clinics, Surgical Centers) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年DVT预防帮浦市场规模为3.8306亿美元,2024年将达4.0099亿美元,预计2030年将达5.3258亿美元,复合年增长率为4.81%。
DVT预防帮浦是一种预防深层静脉栓塞症(DVT)的医疗设备。深层静脉栓塞症是一种严重的疾病,血液凝块在身体的深层静脉(通常是腿部)中形成。这些血块可能会产生严重后果,包括阻塞血流或破裂并到达肺部,导致称为肺动脉栓塞的致命疾病。医疗保健提供者越来越多地向高风险患者推荐 DVT 预防措施,推动了 DVT 预防帮浦市场的成长。由于患者经常接受外科手术并长时间无法活动,因此对 DVT 预防设备的需求更大。 DVT 帮浦价格昂贵且有替代品,阻碍了市场成长。随着 DVT 帮浦技术的创新(包括舒适性和易用性的改进)使该设备对医疗保健专业人员和患者都具有吸引力,预计会出现市场成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 38306万美元 |
预测年份 [2024] | 40099万美元 |
预测年份 [2030] | 53258万美元 |
复合年增长率(%) | 4.81% |
区域洞察
美洲的DVT预防帮浦市场高度发达,在临床实务的采用率很高,特别是在美国、巴西和加拿大。该地区医疗卫生基础设施发达,DVT防治意识较高,经济稳定成长。市场成长是由手术相关的不动和肥胖的高发生率所推动的,这些都是 DVT 的危险因子。此外,医疗当局也制定了严格的指导方针,提倡使用血栓症预防设备。由于中国、印度和韩国等国家医疗产业的快速开拓,亚太地区是成长最快的地区。改善医疗基础设施、增加医疗旅游业以及导致 DVT 的文明病盛行率上升是该地区的主要驱动力。欧洲、中东和非洲地区呈现多样化的市场场景。西欧国家(如北美)由于高医疗保健标准和支持采用 DVT 预防帮浦的监管政策而拥有稳固的市场影响。同时,受医疗基础设施变化和 DVT 预防意识低下的影响,中东和非洲地区也出现了成长。然而,由于医疗保健设施的改善和政府针对医疗保健的倡议的增加,中东一些国家呈现出有希望的成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在 DVT 预防帮浦市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对 DVT 预防帮浦市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对 DVT 预防帮浦市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[183 Pages Report] The DVT Preventive Pump Market size was estimated at USD 383.06 million in 2023 and expected to reach USD 400.99 million in 2024, at a CAGR 4.81% to reach USD 532.58 million by 2030.
A DVT preventive pump is a medical device designed to prevent deep vein thrombosis (DVT). Deep vein thrombosis is a serious condition where blood clots form in the deep veins of the body, commonly in the legs. These clots can have severe consequences, such as blocking blood flow or breaking off and traveling to the lungs, causing a potentially fatal condition known as pulmonary embolism. Increasing recommendations by healthcare providers for DVT preventive measures for at-risk patients contribute to the growth of the DVT preventive pumps market. The high number of surgical procedures, which often lead to prolonged periods of immobility, further drives the need for DVT preventive devices. The high cost of DVT pumps and the availability of certain alternatives hamper the market growth. Rising innovations in DVT pump technology, such as enhanced comfort and ease of use that make these devices more appealing to both healthcare providers and patients are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 383.06 million |
Estimated Year [2024] | USD 400.99 million |
Forecast Year [2030] | USD 532.58 million |
CAGR (%) | 4.81% |
Regional Insights
The market for DVT preventive pumps in the Americas is highly developing, with a significant adoption rate in clinical settings, particularly in the United States, Brazil, and Canada. This region shows stable growth due to the well-established healthcare infrastructure and high awareness of preventive treatments for DVT. Factors contributing to the market growth include the high prevalence of surgery-related immobility and obesity which are risk factors for DVT. Additionally, there are strict guidelines from healthcare authorities promoting the use of thrombosis-prevention devices. The APAC region is experiencing the fastest growth in the DVT preventive pump market, which is attributed to the rapidly developing healthcare sectors in countries such as China, India, and South Korea. Improvements in healthcare infrastructure, rising medical tourism, and increasing prevalence of lifestyle diseases that predispose individuals to DVT are significant drivers in this region. The EMEA region presents a diverse market scenario. Western European countries display a robust market presence similar to North America due to high healthcare standards and regulatory policies that support the adoption of DVT preventive pumps. Conversely, the Middle East and Africa exhibit growth, influenced by variable healthcare infrastructure and lower awareness about DVT prevention. Nonetheless, some countries in the Middle East show promising growth due to improving healthcare facilities and increasing government initiatives focused on healthcare.
Market Insights
The market dynamics represent an ever-changing landscape of the DVT Preventive Pump Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the DVT Preventive Pump Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the DVT Preventive Pump Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
AIROS Medical Introduces Advanced AIROS 6P Compression Device for Comprehensive Lymphatic and Venous Treatment
AIROS Medical Inc. launched the AIROS 6P sequential compression device, complemented by specialized pants-like garments, designed to alleviate swelling in the abdomen, pelvis, and legs. This latest model, which follows the earlier release of the AIROS 8P, includes significant enhancements such as Peristaltic Mode functionality, which mimics natural wave-like muscle contractions, preferred for upper extremity treatments. The AIROS 6P, a 6-chamber pneumatic compression device, continues to be covered by Medicare and commercial insurers under HCPCS Code E0651, ensuring broad accessibility. [Published On: 2023-09-12]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the DVT Preventive Pump Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the DVT Preventive Pump Market, highlighting leading vendors and their innovative profiles. These include 3A Health Care S.R.L., Bio Compression Systems, Inc., Breg, Inc., Cardinal Health, Inc., Devon Medical Products, DJO Global, FlowAid Medical Technologies Corp., GE Healthcare, Huntleigh Healthcare Limited, Medline Industries, Inc., Medtronic PLC, Mego Afek ltd., NormaTec Industries LP, Oska Wellness, Smiths Medical, Stryker Corporation, SunTech Medical, Inc., Tactile Systems Technology Inc., Talley Group Limited, Vasomedical, Inc., and Zimmer Biomet.
Market Segmentation & Coverage